Management ChangeJun 30, 2026, 04:38 PM
Ardent Health Finalizes Separation Agreement with Former CEO Martin Bonick
AI Summary
Ardent Health, Inc. announced the finalization of a separation agreement with its former President and Chief Executive Officer, Martin J. Bonick. Mr. Bonick had previously departed from his role and stepped down from the Board on June 2, 2026. The agreement, effective June 2, 2026, outlines severance benefits consistent with a termination without "Cause" and specifies that the vesting of his equity awards will follow existing incentive plans. Additionally, Mr. Bonick is subject to non-competition and non-solicitation covenants for twelve months.
Key Highlights
- Martin J. Bonick departed as President and CEO, and stepped down from the Board, effective June 2, 2026.
- Separation agreement and general release with Mr. Bonick was entered into on June 26, 2026.
- Mr. Bonick will receive severance benefits consistent with termination without "Cause".
- Vesting of restricted stock units and shares will be governed by the Company's incentive award plan.
- Mr. Bonick is subject to 12-month non-competition and non-solicitation covenants.
Price Impact
More from ARDT